Table of Content


Introduction
Pseudomos aeruginosa Infections - Overview
Pseudomos aeruginosa Infections - Therapeutics Development
Pseudomos aeruginosa Infections - Therapeutics Assessment
Pseudomos aeruginosa Infections - Companies Involved in Therapeutics Development
Pseudomos aeruginosa Infections - Drug Profiles
Pseudomos aeruginosa Infections - Dormant Projects
Pseudomos aeruginosa Infections - Discontinued Products
Pseudomos aeruginosa Infections - Product Development Milestones
Appendix



List of Figures


Figure 1: Number of Products under Development for Pseudomonas aeruginosa Infections, H2 2019
Figure 2: Number of Products under Development by Companies, H2 2019
Figure 3: Number of Products under Development by Universities/Institutes, H2 2019
Figure 4: Number of Products by Top 10 Targets, H2 2019
Figure 5: Number of Products by Stage and Top 10 Targets, H2 2019
Figure 6: Number of Products by Top 10 Mechanism of Actions, H2 2019
Figure 7: Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Figure 8: Number of Products by Top 10 Routes of Administration, H2 2019
Figure 9: Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Figure 10: Number of Products by Top 10 Molecule Types, H2 2019
Figure 11: Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables


Table 1: Number of Products under Development for Pseudomonas aeruginosa Infections, H2 2019
Table 2: Number of Products under Development by Companies, H2 2019
Table 3: Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Table 4: Number of Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Table 5: Number of Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Table 6: Number of Products under Development by Universities/Institutes, H2 2019
Table 7: Number of Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Table 8: Products under Development by Companies, H2 2019
Table 9: Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Table 10: Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Table 11: Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Table 12: Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Table 13: Products under Development by Companies, H2 2019 (Contd..5), H2 2019
Table 14: Products under Development by Universities/Institutes, H2 2019
Table 15: Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Table 16: Number of Products by Stage and Target, H2 2019
Table 17: Number of Products by Stage and Target, H2 2019 (Contd..1), H2 2019
Table 18: Number of Products by Stage and Mechanism of Action, H2 2019
Table 19: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019
Table 20: Number of Products by Stage and Route of Administration, H2 2019
Table 21: Number of Products by Stage and Molecule Type, H2 2019
Table 22: Pseudomonas aeruginosa Infections - Pipeline by Acies Bio doo, H2 2019
Table 23: Pseudomonas aeruginosa Infections - Pipeline by Affilogic SAS, H2 2019
Table 24: Pseudomonas aeruginosa Infections - Pipeline by Affinivax Inc, H2 2019
Table 25: Pseudomonas aeruginosa Infections - Pipeline by Agile Sciences Inc, H2 2019
Table 26: Pseudomonas aeruginosa Infections - Pipeline by AGILeBiotics BV, H2 2019
Table 27: Pseudomonas aeruginosa Infections - Pipeline by AiCuris GmbH & Co KG, H2 2019
Table 28: Pseudomonas aeruginosa Infections - Pipeline by Akthelia Pharmaceuticals Ltd, H2 2019
Table 29: Pseudomonas aeruginosa Infections - Pipeline by AlgiPharma AS, H2 2019
Table 30: Pseudomonas aeruginosa Infections - Pipeline by Amicrobe Inc, H2 2019
Table 31: Pseudomonas aeruginosa Infections - Pipeline by AMR Centre Ltd, H2 2019
Table 32: Pseudomonas aeruginosa Infections - Pipeline by Appili Therapeutics Inc, H2 2019
Table 33: Pseudomonas aeruginosa Infections - Pipeline by Aridis Pharmaceuticals Inc, H2 2019
Table 34: Pseudomonas aeruginosa Infections - Pipeline by Armata Pharmaceuticals Inc, H2 2019
Table 35: Pseudomonas aeruginosa Infections - Pipeline by AstraZeneca Plc, H2 2019
Table 36: Pseudomonas aeruginosa Infections - Pipeline by Atterx Biotherapeutics Inc, H2 2019
Table 37: Pseudomonas aeruginosa Infections - Pipeline by Aurora Oncology Inc, H2 2019
Table 38: Pseudomonas aeruginosa Infections - Pipeline by Biolytics Pharma, H2 2019
Table 39: Pseudomonas aeruginosa Infections - Pipeline by Biolytx Pharmaceuticals Corp, H2 2019
Table 40: Pseudomonas aeruginosa Infections - Pipeline by Biomendics LLC, H2 2019
Table 41: Pseudomonas aeruginosa Infections - Pipeline by BlueWillow Biologics Inc, H2 2019
Table 42: Pseudomonas aeruginosa Infections - Pipeline by Boston Pharmaceuticals Inc, H2 2019
Table 43: Pseudomonas aeruginosa Infections - Pipeline by Bugworks Research India Pvt Ltd, H2 2019
Table 44: Pseudomonas aeruginosa Infections - Pipeline by Catabasis Pharmaceuticals Inc, H2 2019
Table 45: Pseudomonas aeruginosa Infections - Pipeline by Centauri Therapeutics Ltd, H2 2019
Table 46: Pseudomonas aeruginosa Infections - Pipeline by Combioxin SA, H2 2019
Table 47: Pseudomonas aeruginosa Infections - Pipeline by ContraFect Corp, H2 2019
Table 48: Pseudomonas aeruginosa Infections - Pipeline by CSA Biotechnologies LLC, H2 2019
Table 49: Pseudomonas aeruginosa Infections - Pipeline by Cyclacel Pharmaceuticals Inc, H2 2019
Table 50: Pseudomonas aeruginosa Infections - Pipeline by Destiny Pharma Plc, H2 2019
Table 51: Pseudomonas aeruginosa Infections - Pipeline by Eligochem Ltd, H2 2019
Table 52: Pseudomonas aeruginosa Infections - Pipeline by EnBiotix Inc, H2 2019
Table 53: Pseudomonas aeruginosa Infections - Pipeline by Entasis Therapeutics Inc, H2 2019
Table 54: Pseudomonas aeruginosa Infections - Pipeline by Evaxion Biotech ApS, H2 2019
Table 55: Pseudomonas aeruginosa Infections - Pipeline by Evotec SE, H2 2019
Table 56: Pseudomonas aeruginosa Infections - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
Table 57: Pseudomonas aeruginosa Infections - Pipeline by Fedora Pharmaceuticals Inc, H2 2019
Table 58: Pseudomonas aeruginosa Infections - Pipeline by Forge Therapeutics Inc, H2 2019
Table 59: Pseudomonas aeruginosa Infections - Pipeline by Helix BioMedix Inc, H2 2019
Table 60: Pseudomonas aeruginosa Infections - Pipeline by Hsiri Therapeutics LLC, H2 2019